NDA 050219

LILLY

FDA Drug Application

Application #050219

Application Sponsors

NDA 050219

LILLY

Marketing Status

• Discontinued: 001

Application Products

001

CAPSULE;ORAL

250MG

0

KAFOCIN

CEPHALOGLYCIN

FDA Submissions

ORIG

1

AP

1970-06-12

Submissions Property Types

ORIG

1

Null

0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50219
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)